Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,150,000 | 3,296,000 | 3,599,000 | 4,464,000 | 3,693,000 |
| Marketable Securities | 9,000 | 10,000 | 20,000 | 21,000 | 21,000 |
| Inventories | 5,924,000 | 6,118,000 | 6,072,000 | 6,000,000 | 5,669,000 |
| Other current assets | 8,042,000 | 8,418,000 | 7,982,000 | 7,600,000 | 7,224,000 |
| TOTAL | $17,510,000 | $17,842,000 | $17,673,000 | $18,085,000 | $16,997,000 |
| Non-Current Assets | |||||
| PPE Net | 10,048,000 | 10,132,000 | 9,918,000 | 9,971,000 | 10,073,000 |
| Intangibles | 23,766,000 | 23,982,000 | 22,110,000 | 23,184,000 | 22,497,000 |
| Other Non-Current Assets | 9,794,000 | 9,383,000 | 9,557,000 | 9,465,000 | 9,896,000 |
| TOTAL | $43,608,000 | $43,497,000 | $41,585,000 | $42,620,000 | $42,466,000 |
| Total Assets | $61,118,000 | $61,339,000 | $59,258,000 | $60,705,000 | $59,463,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,875,000 | N/A | N/A | N/A | 2,181,000 |
| Accounts payable and accrued liabilities | 3,535,000 | 15,675,000 | 14,820,000 | 15,149,000 | 3,462,000 |
| Other current liabilities | 1,348,000 | 1,236,000 | 1,134,000 | 1,175,000 | 1,172,000 |
| TOTAL | $21,391,000 | $21,334,000 | $20,378,000 | $20,831,000 | $21,697,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,015,000 | N/A | N/A | N/A | 13,703,000 |
| Other Non-Current Liabilities | 9,072,000 | 24,259,000 | 24,579,000 | 26,319,000 | 10,081,000 |
| TOTAL | $23,771,000 | $24,253,000 | $24,526,000 | $26,220,000 | $24,680,000 |
| Total Liabilities | $45,162,000 | $45,587,000 | $44,904,000 | $47,051,000 | $46,377,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,349,000 | 1,349,000 | 1,349,000 | 1,349,000 | 1,348,000 |
| Retained earnings | 10,209,000 | 10,016,000 | 8,797,000 | 8,307,000 | 7,796,000 |
| Other shareholders' equity | 1,321,000 | 1,297,000 | 1,159,000 | 1,017,000 | 1,054,000 |
| TOTAL | $16,377,000 | $16,148,000 | $14,791,000 | $14,157,000 | $13,671,000 |
| Total Liabilities And Equity | $61,539,000 | $61,735,000 | $59,695,000 | $61,208,000 | $60,048,000 |